Trust Company of Vermont’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.28M | Buy |
+46,466
| New | +$6.97M | 0.27% | 80 |
|
|
2025
Q4 | $6.31M | Buy |
45,745
+6
| +0% | +$786 | 0.26% | 86 |
|
|
2025
Q3 | $5.87M | Sell |
45,739
-819
| -2% | -$99.9K | 0.26% | 82 |
|
|
2025
Q2 | $5.63M | Sell |
46,558
-338
| -0.7% | -$38.1K | 0.27% | 85 |
|
|
2025
Q1 | $5.23M | Sell |
46,896
-1,072
| -2% | -$114K | 0.26% | 89 |
|
|
2024
Q4 | $4.67M | Sell |
47,968
-397
| -0.8% | -$42.3K | 0.23% | 95 |
|
|
2024
Q3 | $5.56M | Sell |
48,365
-313
| -0.6% | -$35.5K | 0.28% | 88 |
|
|
2024
Q2 | $5.18M | Sell |
48,678
-589
| -1% | -$59.1K | 0.28% | 88 |
|
|
2024
Q1 | $4.77M | Buy |
49,267
+5,082
| +12% | +$521K | 0.27% | 93 |
|
|
2023
Q4 | $4.46M | Sell |
44,185
-8,749
| -17% | -$844K | 0.3% | 86 |
|
|
2023
Q3 | $5.39M | Sell |
52,934
-6,172
| -10% | -$626K | 0.36% | 77 |
|
|
2023
Q2 | $5.96M | Sell |
59,106
-2,679
| -4% | -$268K | 0.39% | 72 |
|
|
2023
Q1 | $5.68M | Sell |
61,785
-608
| -1% | -$53.1K | 0.4% | 72 |
|
|
2022
Q4 | $5.66M | Sell |
62,393
-3,507
| -5% | -$295K | 0.41% | 73 |
|
|
2022
Q3 | $5.01M | Sell |
65,900
-1,307
| -2% | -$108K | 0.4% | 78 |
|
|
2022
Q2 | $5.68M | Sell |
67,207
-1,521
| -2% | -$133K | 0.43% | 75 |
|
|
2022
Q1 | $6.03M | Sell |
68,728
-842
| -1% | -$72.9K | 0.41% | 83 |
|
|
2021
Q4 | $6.09M | Sell |
69,570
-2,998
| -4% | -$249K | 0.38% | 80 |
|
|
2021
Q3 | $5.93M | Sell |
72,568
-1,492
| -2% | -$134K | 0.42% | 75 |
|
|
2021
Q2 | $6.76M | Sell |
74,060
-381
| -0.5% | -$33.9K | 0.47% | 64 |
|
|
2021
Q1 | $6.36M | Sell |
74,441
-7,826
| -10% | -$702K | 0.48% | 65 |
|
|
2020
Q4 | $7.77M | Sell |
82,267
-1,984
| -2% | -$173K | 0.62% | 52 |
|
|
2020
Q3 | $7.33M | Sell |
84,251
-2,619
| -3% | -$227K | 0.67% | 47 |
|
|
2020
Q2 | $7.59M | Sell |
86,870
-22,611
| -21% | -$1.95M | 0.75% | 42 |
|
|
2020
Q1 | $9.03M | Buy |
109,481
+382
| +0.4% | +$34.1K | 0.84% | 38 |
|
|
2019
Q4 | $10.3M | Sell |
109,099
-1,050
| -1% | -$94.2K | 0.78% | 44 |
|
|
2019
Q3 | $9.57M | Sell |
110,149
-1,846
| -2% | -$166K | 0.77% | 45 |
|
|
2019
Q2 | $10.2M | Sell |
111,995
-13,885
| -11% | -$1.18M | 0.85% | 40 |
|
|
2019
Q1 | $10.8M | Sell |
125,880
-1,088
| -0.9% | -$87.3K | 0.93% | 36 |
|
|
2018
Q4 | $9.76M | Sell |
126,968
-543
| -0.4% | -$42.3K | 0.94% | 33 |
|
|
2018
Q3 | $9.85M | Buy |
127,511
+270
| +0.2% | +$20K | 0.83% | 38 |
|
|
2018
Q2 | $8.61M | Buy |
127,241
+1,189
| +0.9% | +$82.1K | 0.77% | 44 |
|
|
2018
Q1 | $9.13M | Buy |
126,052
+1,220
| +1% | +$92.9K | 0.86% | 35 |
|
|
2017
Q4 | $9.39M | Buy |
124,832
+878
| +0.7% | +$66.2K | 0.87% | 36 |
|
|
2017
Q3 | $9.54M | Buy |
123,954
+467
| +0.4% | +$35.3K | 0.95% | 30 |
|
|
2017
Q2 | $9.24M | Buy |
123,487
+3,915
| +3% | +$277K | 0.95% | 28 |
|
|
2017
Q1 | $7.96M | Buy |
119,572
+2,275
| +2% | +$152K | 0.86% | 35 |
|
|
2016
Q4 | $7.66M | Buy |
117,297
+11,972
| +11% | +$777K | 0.88% | 32 |
|
|
2016
Q3 | $7.45M | Buy |
105,325
+4,527
| +4% | +$330K | 0.93% | 30 |
|
|
2016
Q2 | $7.45M | Buy |
100,798
+4,582
| +5% | +$317K | 0.99% | 27 |
|
|
2016
Q1 | $6.25M | Buy |
96,216
+15,868
| +20% | +$1.08M | 0.87% | 34 |
|
|
2015
Q4 | $6.19M | Buy |
80,348
+1,828
| +2% | +$145K | 0.89% | 35 |
|
|
2015
Q3 | $6.47M | Buy |
78,520
+471
| +0.6% | +$41.9K | 1.01% | 27 |
|
|
2015
Q2 | $6.88M | Sell |
78,049
-295
| -0.4% | -$27.1K | 1% | 29 |
|
|
2015
Q1 | $6.92M | Sell |
78,344
-1,028
| -1% | -$91.2K | 1.01% | 32 |
|
|
2014
Q4 | $6.59M | Sell |
79,372
-194
| -0.2% | -$16.1K | 0.96% | 33 |
|
|
2014
Q3 | $6.71M | Buy |
79,566
+309
| +0.4% | +$25K | 1.02% | 27 |
|
|
2014
Q2 | $6.43M | Buy |
79,257
+1,158
| +1% | +$91.1K | 0.99% | 27 |
|
|
2014
Q1 | $5.95M | Buy |
78,099
+302
| +0.4% | +$22K | 0.97% | 28 |
|
|
2013
Q4 | $5.6M | Buy |
77,797
+2,428
| +3% | +$169K | 0.94% | 30 |
|
|
2013
Q3 | $5.18M | Buy |
75,369
+2,928
| +4% | +$194K | 0.95% | 30 |
|
|
2013
Q2 | $4.59M | Buy |
+72,441
| New | +$4.71M | 0.9% | 33 |
|
Other funds holding NVS
TAM
SI
Trust Company of Vermont's NVS Position: Q2 2026 in Review
Trust Company of Vermont opened a new position in Novartis (NVS) in Q2 2026: 46,466 shares worth $7.28M. The stake represents 0.27% of the portfolio and ranks #80 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in NVS as recently as Q4 2025.
Trust Company of Vermont first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.8M in Q1 2019. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Trust Company of Vermont held 46,466 shares of Novartis worth $7.28M as of Q2 2026.
- Novartis was a new Trust Company of Vermont position in Q2 2026.
- Novartis made up 0.27% of Trust Company of Vermont's portfolio in Q2 2026, its #80 holding.
- Trust Company of Vermont first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Trust Company of Vermont's Novartis position peaked at $10.8M in Q1 2019.
- 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.